FTC drops probe over marketing of topical spray
The Federal Trade Commission has dropped its investigation into whether a homeopathic topical spray was falsely marketed as an effective nerve pain reliever after the product’s claims were modified.
Subscription required to view this article.
This content can only be accessed by FTCWatch subscribers. If you are an FTCWatch subscriber, please login
to access this content
If you do not currently subscribe to FTCWatch please contact us for subscription information:
FTCWatch is delivered in the following formats: via email alert and online at mlexwatch.com/ftcwatch